Hypothesis

Progressive loss of vagal efferent output from the dorsal motor nucleus of the vagus (DMV) in aging reduces acetylcholine release onto intestinal mesenchymal niche cells. This diminishes α7‑nicotinic acetylcholine receptor (α7nAChR)–mediated PI3K/Akt signaling, leading to sustained GSK3β activity, increased β‑catenin degradation, and a flattened Wnt/β‑catenin gradient along the crypt axis. The resulting Wnt dysregulation impairs intestinal stem cell (ISC) proliferation, promotes premature senescence, and weakens the mucosal barrier, thereby amplifying systemic inflammation and brain aging.

Mechanistic Rationale

• Vagal efferents release acetylcholine that binds α7nAChR on subepithelial myofibroblasts and pericryptal fibroblasts, activating PI3K/Akt and inhibiting GSK3β [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1362239/full].
• Active Akt phosphorylates GSK3β (Ser9), suppressing its kinase activity and allowing β‑catenin accumulation, which is essential for maintaining the Wnt gradient that drives ISC proliferation [https://www.aging-us.com/article/101279/text].
• Age‑related neurodegeneration in the DMV reduces vagal tone, decreasing acetylcholine in the gut wall [https://www.aging-us.com/article/101677/text].
• Loss of α7nAChR signaling shifts the balance toward GSK3β‑mediated β‑catenin degradation, collapsing the Wnt gradient and causing ISC hyperproliferation followed by senescence/apoptosis [https://www.aging-us.com/article/101279/text].
• Senescent ISCs secrete SASP factors (IL‑6, TNF‑α) that increase permeability, reduce short‑chain fatty acid production, and fuel systemic inflammation that feeds back to the CNS via vagal afferents and circulating cytokines [https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1362239/full].

Testable Predictions

1. Aged mice will show reduced cholinergic signaling markers (ChAT, VAChT) in the myenteric plexus and lower α7nAChR‑dependent p‑Akt levels in pericryptal fibroblasts compared with young adults.
2. Restoring vagal efferent activity chemogenetically (e.g., hM3Dq DREADDs in DMV neurons) in aged mice will increase p‑Akt, stabilize β‑catenin, and restore a normal Wnt gradient along the crypt axis.
3. Rescue of Wnt signaling will normalize ISC proliferation indices (Ki‑67, Lgr5+ cells), reduce senescence markers (p16^Ink4a^, SA‑β‑gal), and improve barrier function (FITC‑dextran permeability, zonulin‑1 expression).
4. Improved barrier integrity will lower circulating IL‑6 and TNF‑α, decrease microglial activation in the hippocampus, and ameliorate age‑related cognitive decline in behavioral assays.
5. Blocking α7nAChR with methyllycaconitine (MLA) in young mice will mimic the aged phenotype: Wnt gradient loss, ISC dysfunction, and increased inflammation, confirming sufficiency of the pathway.

Experimental Design

• Animals: Young (3 mo) and aged (20 mo) C57BL/6 mice; subsets receive DMV‑targeted hM3Dq or hM4Di DREADDs via AAV‑synapsin constructs.
• Interventions: Clozapine‑N‑oxide (CNO) administration to activate or inhibit vagal efferents for 4 weeks; control groups receive vehicle.
• Readouts:
  • qPCR/Western blot for ChAT, VAChT, α7nAChR, p‑Akt (Ser473), GSK3β (Ser9), total and active β‑catenin in isolated intestinal subepithelial fibroblasts.
  • Immunofluorescence for β‑catenin localization along crypt‑villus axis; Wnt reporter (TOPflash) activity in enteroid cultures.
  • ISC quantification: Lgr5‑EGFP+ cells, Ki‑67 staining, colony‑forming unit assays.
  • Senescence: p16^Ink4a^ immunostaining, SA‑β‑gal activity.
  • Barrier: FITC‑dextran serum flux, zonulin‑1, occludin expression.
  • Cytokines: ELISA for IL‑6, TNF‑α in serum and colonic lavage.
  • CNS: Iba1 immunoreactivity in hippocampus, Morris water maze performance.
• Pharmacologic validation: Separate cohort of young mice treated with MLA (α7nAChR antagonist) to test whether pharmacological blockade reproduces aged phenotypes.

Falsifiability

If vagal efferent activation fails to increase p‑Akt, stabilize β‑catenin, or rescue ISC proliferation and barrier function in aged mice, the hypothesis that diminished vagal cholinergic signaling drives intestinal Wnt collapse would be refuted. Conversely, if MLA treatment in young mice does not induce Wnt gradient loss or ISC senescence, the proposed mechanism would lack sufficient explanatory power.

Implications

Confirming this brain‑to‑gut axis would reposition the vagus nerve as a modulatable lever for aging interventions. Neuromodulation strategies (e.g., transcutaneous vagus nerve stimulation) could be tested for their capacity to preserve intestinal stemness, curb inflammaging, and extend healthspan—offering a direct, mechanism‑based counterpoint to microbiome‑centric approaches.